OR WAIT null SECS
July 01, 2015
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about biosimilar development trends.
Brady Cole, VP of Commercial Operations, at ABEC, spoke with Pharmaceutical Technology about biopharmaceutical manufacturing processes.
Barry Holtz, Principal, at Holtz Biopharma Consulting, and Klyo Collaborative, spoke with Pharmaceutical Technology about collaborative success strategies for biopharm companies.
June 29, 2015
The new column features Natrix’s signature macroporous hydrogel.
June 26, 2015
More biopharma companies choose outside service providers for assay testing.
June 25, 2015
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
June 24, 2015
Juniper Pharma Services has entered into a long-term collaboration with OxSonics to support the development, scale-up, and GMP manufacturing of OxSonics’ proprietary sono-sensitive particles.
The agency clarifies its requirements for allowable excess volume and labeled vial fill size in injectables and biologics.
